Secukinumab Shows Higher Symptomatic improvement Versus Infliximab in Psoriatic Arthritis: Comparative Effectiveness Up To 1 Year Assessed by Matching-Adjusted Indirect Comparisons
VALUE IN HEALTH（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要